Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Granulosa cell tumor of the ovary × darolutamide × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 13 Salivary Gland Neoplasms 2 Granulosa cell tumor of the ovary 1 Bulbo-Spinal Atrophy, X-Linked 1 Biochemically Recurrent Prostate Cancer 1

Interventions

luprolide acetate gel depot 1 exemestane 1 darolutamide 1 X-Rays 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06169124 2026-03-18

Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting

Granulosa cell tumor of the ovary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡